Source:http://linkedlifedata.com/resource/pubmed/id/11349446
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0024554,
umls-concept:C0034693,
umls-concept:C0039597,
umls-concept:C0039763,
umls-concept:C0043227,
umls-concept:C0178602,
umls-concept:C0178784,
umls-concept:C0205341,
umls-concept:C0220825,
umls-concept:C0282116,
umls-concept:C0600688,
umls-concept:C0748342,
umls-concept:C1280500,
umls-concept:C2603343
|
pubmed:dateCreated |
2001-5-14
|
pubmed:abstractText |
The effects of theobromine, a xanthine derivative, on the testis were compared between rats dosed for 2 and 4 weeks to determine whether a 2-week dosing period is long enough to detect toxicity. Theobromine was administered orally to male Sprague-Dawley rats at dose levels of 250 and 500 mg/kg for 2 weeks starting at the age of 6 or 8 weeks, and for 4 weeks from the age of 6 weeks. Histopathological examination of reproductive organs revealed toxic findings in the testis at 500 mg/kg after 2 weeks of dosing at both ages, and at 250 and 500 mg/kg after 4 weeks of dosing. The primary findings were degeneration/necrosis and desquamation of spermatids and spermatocytes, vacuolization of seminiferous tubules, and multinucleated giant cell formation. These findings were present mainly in stages I-VI and XII-XIV. From these results, it is concluded that the toxic effects of theobromine on the testis can be detected by repeated dosing for 2 weeks as well as for 4 weeks.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0388-1350
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25 Spec No
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
211-21
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11349446-Administration, Oral,
pubmed-meshheading:11349446-Animals,
pubmed-meshheading:11349446-Atrophy,
pubmed-meshheading:11349446-Body Weight,
pubmed-meshheading:11349446-Dose-Response Relationship, Drug,
pubmed-meshheading:11349446-Epididymis,
pubmed-meshheading:11349446-Male,
pubmed-meshheading:11349446-Organ Size,
pubmed-meshheading:11349446-Prostate,
pubmed-meshheading:11349446-Rats,
pubmed-meshheading:11349446-Rats, Sprague-Dawley,
pubmed-meshheading:11349446-Seminal Vesicles,
pubmed-meshheading:11349446-Seminiferous Epithelium,
pubmed-meshheading:11349446-Spermatogenesis,
pubmed-meshheading:11349446-Testis,
pubmed-meshheading:11349446-Theobromine,
pubmed-meshheading:11349446-Time Factors,
pubmed-meshheading:11349446-Toxicity Tests
|
pubmed:year |
2000
|
pubmed:articleTitle |
Collaborative work to evaluate toxicity on male reproductive organs by repeated dose studies in rats 22). Effects of 2- and 4-week administration of theobromine on the testis.
|
pubmed:affiliation |
Developmental Research Laboratories, Dainippon Pharmaceutical Co., Ltd., 33-94 Enoki-cho, Suita-shi, Osaka 564-0053, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|